Disorders of facial motor function

Current Opinion in Ophthalmology

Volumn 7, Issue 6, 1996, Pages 48-52

  Boghen, Dan R ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

APRAXIA; BLEPHAROSPASM; CLINICAL EXAMINATION; COMPRESSION THERAPY; EYELID DISEASE; FACE MUSCLE; FACIAL NERVE PARALYSIS; HUMAN; MYOKYMIA; NEUROOPHTHALMOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0030424972     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-199612000-00008     Document Type: Review

References (43)

1. Hallett M, Daroff RB: Blepharospasm: report of a workshop. Neurology 1996, 46:1213-1218. An excellent report of a workshop on blepharospasm that provides a clear and concise discussion of the essential aspects of the anatomy and physiology of lid function and the pathophysiology, clinical aspects, and treatment of blepharospasm.
2. Aramideh M, Ongerboer de Visser BW, Devriese PP, Bour LJ, Speelman JD: Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain 1994, 117:27-38.
3. Aramideh M, Eekhof JLA, Bour LJ, Koelman JHTM, Speelman JD, Ongerboer de Visser BW: Electromyography and recovery of the blink reflex in involuntary eyelid closure: a comparative study. J Neurol Neurosurg Psychiatry 1995, 58:692-698.
4. Greene P, Kang UJ, Fahn S: Spread of symptoms in idiopathic torsion dystonia. Mov Disord 1995, 10:143-152.
5. Jankovic J: Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. In Advances in Neurology, vol 9, Facial Dyskynesias. Edited by Jankovic J, Tolosa E. New York: Raven Press; 1988:103-116.
6. Aramideh M, Ongerboer de Visser BW, Holstege G, Majoie CBLM, Speelman JD: Blepharospasm in association with a lower pontine lesion. Neurology 1996, 46:476-478.
7. Zolli CL: A central dystonia causes spastic lower eyelid entropion: a hypothesis. Ophthalmic Surg 1995, 26:362-366.
8. Schreiber S, Pick CG: Fluoxetine for blepharospasm: interaction of serotonin and dopamine. J Nerv Ment Dis 1995, 183:719-721.
9. Ainsworth JR, Kraft SP: Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Opthalmology 1995, 102:2036-3040.
10. Singer M: Botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Opthalmology 1996, 103:348.
11. Carruthers J, Carruthers A, Bagaric D: Can ptosis incidence be reduced after lid injections of botulinum A exotoxin for blepharospasm and hemifacial spasm? Can J Ophthalmol 1995, 30:147.
12. Albanese A, Bentivoglio AR, Colosimo C, Galardi G, Maderna L, Tonali P: Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. J Neurol Neurosurg Psychiatry 1996, 61:693-694.
13. Jankovic J: Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening. J Neurol Neurosurg Psychiatry 1996, 60:704.
14. Aramideh M, Ongerboer de Visser BW, Brans JWM, Koelman JHTM, Speelman JD: Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 1995, 59:309-311.
15. Mezaki T, Kaji R, Kohara N, Fujii H, Katayama M, Shimizu T, Kimura J, Brin MF: Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm. Neurology 1995, 45:506-508.
16. Wenning GK, Quinn NP, Daniel SE, Garratt H, Marsden CD: Facial dystonia in pathologically proven multiple system atrophy: a video report. Mov Disord 1996, 11:107-109.
17. Grandas F, Esteban A: Supranuclear palsy of voluntary eyelid closure: electrophysiological correlate. Mov Disord 1996, 11:329-331.
18. Smith D, Ishikawa T, Dhawan V, Winterkorn JS, Eidelberg D: Lid opening apraxia is associated with medial frontal hypometabolism. Mov Disord 1995, 10:341-344.
19. Abe K, Fujimura H, Tatsumi C, Toyooka K, Yorifuji S, Yanagihara T: Eyelid "apraxia" in patients with motor neuron disease. J Neurol Neurosurg Psychiatry 1995, 59:629-632.
20. Adair JC, Williamson DJG, Heilman KM: Eyelid opening apraxia in focal cortical degeneration. J Neurol Neurosurg Psychiatry 1995, 58:508-509.
21. Aramideh M, Ongerboer de Visser BW, Koelman JHTM, Speelman JD: Motor persistence of orbicularis oculi muscle in eyelid-opening disorders. Neurology 1995, 45:897-902.
22. Elston JS: A new variant of blepharospasm. J Neurol Neurosurg Psychiatry 1992, 55:369-371.
23. Jankovic J: Apraxia of lid opening. Mov Disord 1995, 10:686.
24. Lepore V, Defazio G, Acquistapace D, Melpignano C, Pomes L, Lamberti P, Livrea P, Ferrari E: Botulinum A toxin for the so-called apraxia of lid opening. Mov Disord 1995, 10:525-526.
25. Barker FG, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD: Microvascular decompression for hemifacial spasm. J Neurosurg 1995, 82:201-210.
26. Matsuura N, Kondo A: Trigeminal neuralgia and hemifacial spasm as false localizing signs in patients witha contralateral mass of the posterior cranial fossa. J Neurosurg 1996, 84:1067-1071.
27. Kudo A, Suzuki M, Kubo N, Kuruda K, Ogawa A, Iwasaki Y: Schwannoma arising from the intermediate nerve and manifesting as hemifacial spasm. J Neurosurg 1996, 84:277-279.
28. Zhang KW, Shun ZT: Microvascular decompression by the retrosigmoid approach for idiopathic hemifacial spasm: experience with 300 cases. Ann Otol Rhinol Laryngol 1995, 104:610-612.
29. Hosoya T, Watanabe N, Yamaguchi K, Saito S, Nakai O: Three-dimensional-MRI of neurovascular compression in patients with hemifacial spasm. Neuroradiology 1995, 37:350-352.
30. Du C, Korogi Y, Nagahiro S, Sakamoto Y, Takada A, Ushio Y, Hirai T, Higashida Y, Takahashi M: Hemifacial spasm: three-dimensional MR images in the evaluation of neurovascular compression. Radiology 1995, 197:227-231.
31. Kobata H, Kondo A, Kinuta Y, Iwasaki K, Nishioka T, Hasegawa K: Hemifacial spasm in childhood and adolescence. Neurosurgery 1995, 36:710-714.
32. Angibaud G, Moreau MS, Rascol O, Clanet M: Treatment of hemifacial spasm with botulinum toxin. Eur Neurol 1995, 35:43-45.
33. Payner DT, Tew JM Jr: Recurrence of hemifacial spasm after microvascular decompression. Neurosurgery 1996, 38:686-691.
34. Jacobs L, Kaba S, Pullicino P: The lesion causing continuous facial myokymia in multiple sclerosis. Arch Neurol 1994, 51:1115-1119.
35. Blumenthal DT, Gutmann L, Sauter K: Subarachnoid hemorrhage induces facial myokimia. Muscle Nerve 1994, 17:1484-1485.
36. Emre Öge A, Boyaciyan A, Sarp A, Yazici J: Facial myokymia: segmental demylination demonstrated by magnetic stimulation. Muscle Nerve 1996, 19:246-249.
37. Small RG, Fransen SR, Adams R, Owen WL, Taylor RB III: The effect of phenylephrine on Müller muscle: a blepharogram study of eyelid muscle. Opthalmology 1995, 102:599-606.
38. Huffman MD, Baker RS, Stava MW, Chuke JC, Rouholiman BR, Porter JD: Kinematic analysis of eyelid movements in patients recovering from unilateral facial nerve palsy. Neurology 1996, 46:1079-1085.
39. Chuke JC, Baker RS, Porter JD: Bell's palsy-associated blepharospasm relieved by aiding eyelid closure. Ann Neurol 1996, 39:263-268.
40. Kennard C, Illingworth R: Persistent vegetative state. J Neurol Neurosurg Psychiatry 1995, 59:347-348.
41. Averbuch-Heller L, Poonyathalang A, von Maydell RD, Remler BF: Hering's law for eyelids: Still valid. Neurology 1995, 45:1781-1783.
42. Barton JJS, Kardon RH, Slagel D, Thompson HS: Bilateral central ptosis in acquired immunodeficiency syndrome. Can J Neurol Sci 1995, 22:52-55.
43. Ezra E, Plant GT, Plant G: Paroxysmal superior rectus and levator palpebrae spasm: a unique presentation of multiple sclerosis. BMJ, 80:187-188.